The Veteran's residuals of prostate cancer due to radical retropubic prostatectomy are rated at 20 percent effective March 1, 2008. The rating is appropriate as the residuals do not meet criteria for a higher evaluation.
The deciding factor: The medical evidence does not show confirmed local reoccurrence or metastasis of prostate cancer, thus the current 100% rating is no longer warranted and a reduction to 20% is proper based on the residuals of voiding dysfunction.
- Claimed conditions
- prostate carcinoma, Peyronie's disease
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 20%
- Decision date
- March 23, 2010
- Citation
- 1010873
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1010873.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Veteran's Peyronie's disease and erectile dysfunction were denied service connection as not related to his service or a service-connected condition, including valvular heart disease and supraventricular arrhythmia.
- Dismissed
The Veteran's appeals for service connection and ratings were dismissed. The appeal for bilateral recurrent ear wax impaction was dismissed, as the Veteran withdrew his claim. Appeals for a compensable rating for pseudofolliculitis barbae (PFB), erectile dysfunction, residuals from neoplasm of the kidney, and hypertension were also dismissed.
- Dismissed
The Board dismissed the Veteran's appeal regarding service connection for diabetes mellitus, type II. The Veteran was granted an initial 40 percent rating for BPH associated with PTSD and a 30 percent rating for dermatitis from October 23, 2025 onwards. Other issues were either denied or remanded.
- Denied
The Veteran's Peyronie's disease with erectile dysfunction was rated under DC 7522, which assigns a noncompensable (0%) rating for 'erectile dysfunction' with or without penile deformity. The Board found no evidence to support higher ratings and denied the claim for an initial compensable rating.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.